Theriva Biologics Receives FDA Green Light to Advance VCN-01 to Pivotal Phase 3 in Metastatic Pancreatic Cancer
Market Chameleon (Mon, 23-Mar 9:52 AM)
Theriva Biologics Secures Up to $38M in SYN-020 Licensing Deal With Rasayana Therapeutics
Market Chameleon (Thu, 19-Feb 10:34 AM)
